The Business Behind...
Health Care: Drugs
Human Genome Sciences Inc (HGSI: NASDAQ)
$14.24 0.00 | 0.00%
08/02/12 - 04:00 PM ET
Company Profile
Company Profile data is not available for HGSI.
Portfolios with HGSI
- Portfolio NameUser Type
- ContributorHot Biotech Stocks Traded b...
- UserLong Term Stock Picks
- Contributor6 Drug Stocks Unworthy of B...
- ContributorUnder-$10 Setting Up To Tra...
- Userdividend stocks and penny s...
- UserNick
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- Contributor5 Biotech Drug-Launch Stock...
- Userpossible investments
Latest HGSI Headlines from TheStreet
- Stock Futures Waver as Earnings Season Begins 07.09.12 | 09:07 am
- 5 Things You Should Know Before the Stock Market Opens 07.09.12 | 05:07 am
- Stocks to Watch: Alcoa, Best Buy 07.09.12 | 05:07 am
- Celgene Not Buying Human Genome Sciences 07.08.12 | 07:07 pm
- Human Genome Sciences Inc (HGSI): Today's Featured Health Care Winner 07.05.12 | 05:07 pm
- Pipeline Full, Dividend Secure, Says Glaxo CFO
06.22.12 | 07:06 am - 5 Things You Should Know Before the Stock Market Opens 06.15.12 | 06:06 am
- Human Genome Sciences Inc (HGSI): Today's Featured Drugs Loser 06.14.12 | 05:06 pm
- Analysts' Actions: BA, EW, ZNGA, JCP, BBY 06.14.12 | 09:06 am
- Human Genome Sciences Inc (HGSI): Today's Featured Health Care Loser 06.05.12 | 05:06 pm
Press Releases for HGSI
- Securities Lawyers At Goldfarb LLP Seeking More Money, Information For Stockholders Of Human Genome Sciences, Inc. - PR Newswire 07.26.12 | 11:07 am
- Law Office Of Brodsky & Smith, LLC Announces Investigation Of Human Genome Sciences, Inc. - PR Newswire 07.17.12 | 09:07 pm
- Ryan & Maniskas, LLP Announces Investigation Of Human Genome Sciences Inc. - Business Wire 07.17.12 | 03:07 pm
- Human Genome Sciences Shareholder Alert: The Briscoe Law Firm And Powers Taylor, LLP Investigate Sale Of Human Genome Sciences To GlaxoSmithKline Plc - Business Wire 07.17.12 | 10:07 am
- The Law Firm Of Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Human Genome Sciences, Inc. In Connection With The Sale Of The Company To GlaxoSmithKline Plc - Business Wire 07.16.12 | 12:07 pm
- GSK To Acquire Human Genome Sciences For US$14.25 Per Share In Cash - Business Wire 07.16.12 | 09:07 am
- FYI From Human Genome Sciences: GlaxoSmithKline Announces Positive Data From Harmony 8 Phase 3 Trial And Completion Of Clinical Registration Package For Albiglutide In Type 2 Diabetes - Business Wire 07.11.12 | 11:07 am
- Human Genome Sciences Announces Resubmission Of Raxibacumab BLA To FDA - Business Wire 07.10.12 | 07:07 am
- Human Genome Sciences Responds To GSK Extension Of Unsolicited Tender Offer - Business Wire 06.29.12 | 08:06 am
- REPEAT/Human Genome Sciences Announces July 16 As The Date For Submission Of Definitive Acquisition Proposals - Business Wire 06.15.12 | 07:06 am
Partner Headlines for HGSI
- 3 Healthcare Companies With Insider Buys On August 3rd - Seeking Alpha 08.05.12 | 08:08 am
- Biotechs In Motion As New Drug Pipeline Brims - Investor's Business Daily 07.27.12 | 04:07 pm
- Akamai Technologies SURPASSES Estimates and 3 Hot Stocks Rounding Out the Week - Wall St. Cheat Sheet 07.27.12 | 12:07 pm
- Ford Predicts HIGHER Second Half Profits and 2 Morning Hot Stocks Garnering Attention - Wall St. Cheat Sheet 07.27.12 | 12:07 pm
- Sempra Energy DOWNGRADED to Hold and 4 Analyst-Downgraded Shares to Note - Wall St. Cheat Sheet 07.23.12 | 03:07 am
- M&A Weekly Recap: Intel Acquires Whamcloud, PayPal Purchases card.io - Wall St. Cheat Sheet 07.21.12 | 03:07 am
- Glaxo to Increase Stake in Amicus - Analyst Blog - Zacks 07.19.12 | 06:07 pm
- TPG to Acquire Par Pharma for $1.9B - Analyst Blog - Zacks 07.17.12 | 07:07 pm
- BofA LOSES Managing Director and 4 Heavily Traded Shares To See Now - Wall St. Cheat Sheet 07.17.12 | 05:07 am
- Cintas DOWNGRADED to Mkt Perform and 4 Analyst-Downgraded Shares - Wall St. Cheat Sheet 07.17.12 | 03:07 am
